ClinicalTrials.gov
public full text
Public Domain
Necessity of Anti-Arrhythmic Medication After Surgical Ablation for Atrial Fibrillation
The purpose of this study is to determine whether anti arrhythmic medication, specifically Amiodarone, is required during the first three months post surgical ablation. Hypothesis: Amiodarone will not be required during the first three months as verified by no increase in rehospitalizations for recurrent Atrial Fibrillation, and report of sinus rhythm at surgical follow up (approximately 3 weeks from date of surgery), 6 weeks and 12 weeks to include patients' first follow up with cardiologist at approximately 3 months post surgery.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Effect of Perioperative Medications on the Outcomes of Patients Undergoing Cardiac Surgery#894674
- Influence of Inotropic Choice on Morbidity and Mortality in Complex Pediatric Heart Surgery#905382
- Comparing Different Regional Blocks for Analgesia After Off-pump Cardiac Surgery#858914
- Effect of Individualized Catheter Management on Early Removal After Rectal Cancer Surgery#832228
- Optimal Sevoflurane Concentration for Intubation in Combination of Clincal Remifentanil Doses#1073387
Record · ID 804848
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive